Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1992 4
1993 2
1994 4
1995 7
1996 11
1997 3
1998 5
1999 8
2000 2
2001 3
2002 7
2003 13
2004 11
2005 22
2006 21
2007 17
2008 29
2009 26
2010 26
2011 28
2012 27
2013 22
2014 28
2015 19
2016 10
2017 20
2018 11
2019 10
2020 12
2021 7
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

358 results
Results by year
Filters applied: . Clear all
Page 1
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.
Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A, Howell A. Harvie MN, et al. Among authors: frystyk j. Int J Obes (Lond). 2011 May;35(5):714-27. doi: 10.1038/ijo.2010.171. Epub 2010 Oct 5. Int J Obes (Lond). 2011. PMID: 20921964 Free PMC article. Clinical Trial.
A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.
Skytte MJ, Samkani A, Petersen AD, Thomsen MN, Astrup A, Chabanova E, Frystyk J, Holst JJ, Thomsen HS, Madsbad S, Larsen TM, Haugaard SB, Krarup T. Skytte MJ, et al. Among authors: frystyk j. Diabetologia. 2019 Nov;62(11):2066-2078. doi: 10.1007/s00125-019-4956-4. Epub 2019 Jul 23. Diabetologia. 2019. PMID: 31338545 Clinical Trial.
Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations.
Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, Körner A, Obermayer-Pietsch B, Hübener C, Dahlgren J, Frystyk J, Pfeiffer AF, Doering A, Bielohuby M, Wallaschofski H, Arafat AM. Bidlingmaier M, et al. Among authors: frystyk j. J Clin Endocrinol Metab. 2014 May;99(5):1712-21. doi: 10.1210/jc.2013-3059. Epub 2014 Feb 27. J Clin Endocrinol Metab. 2014. PMID: 24606072
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
Thomsen MN, Skytte MJ, Samkani A, Carl MH, Weber P, Astrup A, Chabanova E, Fenger M, Frystyk J, Hartmann B, Holst JJ, Larsen TM, Madsbad S, Magkos F, Thomsen HS, Haugaard SB, Krarup T. Thomsen MN, et al. Among authors: frystyk j. Diabetologia. 2022 Mar;65(3):506-517. doi: 10.1007/s00125-021-05628-8. Epub 2022 Jan 7. Diabetologia. 2022. PMID: 34993571 Free PMC article. Clinical Trial.
Assessment of ghrelin.
Espelund U, Hansen TK, Ørskov H, Frystyk J. Espelund U, et al. Among authors: frystyk j. APMIS Suppl. 2003;(109):140-5. APMIS Suppl. 2003. PMID: 12874966 Review.
Determination of IGFs and their binding proteins.
Hjortebjerg R, Frystyk J. Hjortebjerg R, et al. Among authors: frystyk j. Best Pract Res Clin Endocrinol Metab. 2013 Dec;27(6):771-81. doi: 10.1016/j.beem.2013.08.010. Epub 2013 Sep 6. Best Pract Res Clin Endocrinol Metab. 2013. PMID: 24275189 Review.
Utility of free IGF-I measurements.
Frystyk J. Frystyk J. Pituitary. 2007;10(2):181-7. doi: 10.1007/s11102-007-0025-y. Pituitary. 2007. PMID: 17429595 Review.
358 results